Lv41
460 积分 2023-09-27 加入
Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial
2小时前
待确认
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
2小时前
已完结
Fezolinetant in the treatment of vasomotor symptoms associated with menopause
2小时前
已完结
The 2023 Practitioner’s Toolkit for Managing Menopause
3小时前
已完结
St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
3天前
已完结
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
10天前
已完结
Management of the toxicities of common targeted therapeutics for gynecologic cancers
11天前
已完结
Plasticity mechanisms in vestibular compensation in the cat are improved by an extract of ginkgo biloba (EGb 761)
17天前
已完结
Diagnostic and therapeutic strategies for Meniere's disease of the Japan Society for Equilibrium Research
20天前
已完结
Clinical Practice Guideline: Ménière’s Disease
20天前
已完结
皖公网安备34019202002308
